Phase 1 trial of hepatitis C vaccine shows strong immune reponse. PDF Print
BBC: Forty-one healthy patients were given the vaccine. Scientists said it produced a "very strong" immune response which lasted for at least a year and had no major side-effects. Prof Klenerman said: "The immune responses we've seen are exciting and we are beginning the next stage of trials. While we are hopeful, it could be a long road to any vaccine that protects people against hepatitis C."

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.